Eurorad

Eurorad is a privately-owned, research and development-based company that was formed in 1982. During its early years, Eurorad was focused on mono and polycrystalline semiconductor materials production (CdTe, CdZnTe, etc.), as well as the manufacture of X and Gamma Ray detection equipment.  However, given the demand for more sophisticated radiation detection equipment, Eurorad has developed numerous electronic modules to be used with its detection equipment.  Based upon the upside realized by Eurorad’s entry in to the detector/module market, the Company also developed a wide range of sensor-based systems including probes and nuclear medicine instruments.  Over the years Eurorad has built a significant Research and Development capability which can be leveraged off of for new product development specifically in the field of nuclear imaging for medical applications.
The Company’s main product lines include: , (i) Electronic Modules; and (ii) Detection Systems and Instrumentation for use in nuclear medicine applications and nuclear imaging. The Company also provides ultra pure single and polycrystalline semiconductor materials and Radiation Detectors.
Since its inception, Eurorad has maintained a specialty medical semiconductor research and development focus and has significant expertise in the manufacture of semiconductor materials. The Company is ISO 9001 and ISO 13485 certified.

Eurorad’s expertise in the areas of the manufacture of ultra-pure single and polycrystalline semiconductor materials; and research and development capabilities, have led the company to the development of several radiation-based detection systems and instrumentation.

Per-operative detection probes

Eurorad is one of the world leaders in Radioguided Surgery, and the developer and manufacturer of the Europrobe® System. 

The Europrobe® has been designed for the accurate location of areas of increased radionuclide uptake.  The Europrobe® has become a valuable tool during surgical extractions of malignant tissues and for the identification of “hot” lymph nodes close to the surface of the body.  Lymph node involvement is a major prognostic indicator and treatment planning factor in both melanoma and breast cancer.

Eurorad has also developed an endoscopic gamma probe as an attachment for the Europrobe® system. The gamma probe is a CdTe detector, which can be used for a number of minimally invasive procedures such as mediastinoscopy, thorascopy and laproscopy.  With the advances of procedures in many surgical fields, the gamma probe offers the opportunity to explore the clinical value of new diagnostic procedures such as the sentinel node biopsy in patients with lung, colo-rectal and cervical cancer.

A dual optonuclear probe (detects both the fluorescence as well as the radioactivity) has also been developed, as well as blue-tooth versions of some probes.

Imaging systems

Eurorad has also developed a full line of imaging systems.  These include X and gamma ray imaging systems, which are powerful tools for medical and industrial applications.  These systems can be integrated into several kind of applications including: scanner, tomograph, bone densitometer, industrial non-destructive control systems, luggage and container inspection, and in the automation of industrial process.The first small imaging system for medical application (MINICAM) has received the CE mark in 2003.

List of Eurorad’s know-how:

  • Development of small dimension surgical probes, easy to use and very effective.
  • Development of optical probes, including modules for the emission and detection of photons.
  • Development of analogical and digital electronic modules as well as necessary softwares for the data processing of the signal issued from the sensors up to the images. 
  • In the field of certification : CE marking, and certification of all developed equipments, especially medical equipments.